BMRN logo

BioMarin Pharmaceutical (BMRN) Total liabilities

annual total liabilities:

$1.33B-$559.10M(-29.58%)
December 31, 2024

Summary

  • As of today (June 28, 2025), BMRN annual total liabilities is $1.33 billion, with the most recent change of -$559.10 million (-29.58%) on December 31, 2024.
  • During the last 3 years, BMRN annual total liabilities has fallen by -$408.15 million (-23.47%).
  • BMRN annual total liabilities is now -29.58% below its all-time high of $1.89 billion, reached on December 31, 2023.

Performance

BMRN Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNbalance sheet metrics

quarterly total liabilities:

$1.35B+$22.60M(+1.70%)
March 31, 2025

Summary

  • As of today (June 28, 2025), BMRN quarterly total liabilities is $1.35 billion, with the most recent change of +$22.60 million (+1.70%) on March 31, 2025.
  • Over the past year, BMRN quarterly total liabilities has dropped by -$445.31 million (-24.76%).
  • BMRN quarterly total liabilities is now -35.67% below its all-time high of $2.10 billion, reached on September 30, 2020.

Performance

BMRN quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNbalance sheet metrics

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

BMRN Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-29.6%-24.8%
3 y3 years-23.5%-19.0%
5 y5 years-15.1%-8.7%

BMRN Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-29.6%at low-28.4%+1.7%
5 y5-year-29.6%at low-35.7%+1.7%
alltimeall time-29.6%>+9999.0%-35.7%>+9999.0%

BMRN Total liabilities History

DateAnnualQuarterly
Mar 2025
-
$1.35B(+1.7%)
Dec 2024
$1.33B(-29.6%)
$1.33B(-7.4%)
Sep 2024
-
$1.44B(-19.3%)
Jun 2024
-
$1.78B(-1.0%)
Mar 2024
-
$1.80B(-4.8%)
Dec 2023
$1.89B(+6.7%)
$1.89B(+1.5%)
Sep 2023
-
$1.86B(+4.5%)
Jun 2023
-
$1.78B(+0.3%)
Mar 2023
-
$1.77B(+0.2%)
Dec 2022
$1.77B(+1.9%)
$1.77B(+4.5%)
Sep 2022
-
$1.70B(+3.3%)
Jun 2022
-
$1.64B(-1.8%)
Mar 2022
-
$1.67B(-3.9%)
Dec 2021
$1.74B(-0.2%)
$1.74B(+1.6%)
Sep 2021
-
$1.71B(+3.3%)
Jun 2021
-
$1.66B(+0.8%)
Mar 2021
-
$1.64B(-5.7%)
Dec 2020
$1.74B(+11.1%)
$1.74B(-17.2%)
Sep 2020
-
$2.10B(+1.9%)
Jun 2020
-
$2.07B(+39.3%)
Mar 2020
-
$1.48B(-5.4%)
Dec 2019
$1.57B(+7.4%)
$1.57B(+5.7%)
Sep 2019
-
$1.48B(+3.6%)
Jun 2019
-
$1.43B(-4.4%)
Mar 2019
-
$1.50B(+2.7%)
Dec 2018
$1.46B(-20.0%)
$1.46B(-18.0%)
Sep 2018
-
$1.78B(+2.3%)
Jun 2018
-
$1.74B(-2.8%)
Mar 2018
-
$1.79B(-1.9%)
Dec 2017
$1.82B(+45.1%)
$1.82B(+3.2%)
Sep 2017
-
$1.77B(+44.3%)
Jun 2017
-
$1.22B(+4.7%)
Mar 2017
-
$1.17B(-7.0%)
Dec 2016
$1.26B(-5.4%)
$1.26B(+5.1%)
Sep 2016
-
$1.20B(+2.3%)
Jun 2016
-
$1.17B(-15.0%)
Mar 2016
-
$1.38B(+3.6%)
Dec 2015
$1.33B(+40.2%)
$1.33B(-0.3%)
Sep 2015
-
$1.33B(+3.1%)
Jun 2015
-
$1.29B(+4.7%)
Mar 2015
-
$1.23B(+30.2%)
Dec 2014
$947.49M(+4.9%)
$947.49M(+1.7%)
Sep 2014
-
$931.99M(+5.5%)
Jun 2014
-
$883.72M(+0.4%)
Mar 2014
-
$880.61M(-2.5%)
Dec 2013
$903.02M(+63.4%)
$903.02M(+162.5%)
Sep 2013
-
$344.04M(+0.2%)
Jun 2013
-
$343.26M(-1.4%)
Mar 2013
-
$348.14M(-37.0%)
Dec 2012
$552.58M(+3.7%)
$552.58M(+0.1%)
Sep 2012
-
$552.18M(+3.8%)
Jun 2012
-
$532.10M(+1.3%)
Mar 2012
-
$525.13M(-1.4%)
DateAnnualQuarterly
Dec 2011
$532.66M(-2.3%)
$532.66M(+2.3%)
Sep 2011
-
$520.54M(-5.0%)
Jun 2011
-
$548.09M(+0.9%)
Mar 2011
-
$543.31M(-0.4%)
Dec 2010
$545.37M(-8.3%)
$545.37M(-17.2%)
Sep 2010
-
$658.87M(+5.8%)
Jun 2010
-
$622.55M(+0.3%)
Mar 2010
-
$620.97M(+4.4%)
Dec 2009
$594.98M(-5.6%)
$594.98M(+5.2%)
Sep 2009
-
$565.50M(+0.8%)
Jun 2009
-
$561.00M(-10.4%)
Mar 2009
-
$626.34M(-0.6%)
Dec 2008
$630.02M(+0.4%)
$630.02M(+1.4%)
Sep 2008
-
$621.14M(-1.2%)
Jun 2008
-
$628.53M(+1.6%)
Mar 2008
-
$618.54M(-1.4%)
Dec 2007
$627.55M(+81.6%)
$627.55M(+1.8%)
Sep 2007
-
$616.51M(+0.4%)
Jun 2007
-
$614.04M(+115.4%)
Mar 2007
-
$285.05M(-17.5%)
Dec 2006
$345.63M(+26.7%)
$345.63M(+0.2%)
Sep 2006
-
$344.95M(-17.8%)
Jun 2006
-
$419.83M(-5.1%)
Mar 2006
-
$442.22M(+62.1%)
Dec 2005
$272.76M(-9.4%)
$272.76M(-0.5%)
Sep 2005
-
$274.22M(-1.2%)
Jun 2005
-
$277.69M(+2.4%)
Mar 2005
-
$271.17M(-9.9%)
Dec 2004
$300.94M(+117.3%)
$300.94M(+1.0%)
Sep 2004
-
$298.07M(-2.0%)
Jun 2004
-
$304.23M(+116.5%)
Mar 2004
-
$140.52M(+1.5%)
Dec 2003
$138.49M(+1047.1%)
$138.49M(-2.8%)
Sep 2003
-
$142.48M(-1.0%)
Jun 2003
-
$143.95M(+736.2%)
Mar 2003
-
$17.21M(+42.6%)
Dec 2002
$12.07M(-1.5%)
$12.07M(+7.2%)
Sep 2002
-
$11.26M(+0.6%)
Jun 2002
-
$11.19M(-13.5%)
Mar 2002
-
$12.94M(+5.5%)
Dec 2001
$12.26M(+76.7%)
$12.26M(+96.6%)
Sep 2001
-
$6.24M(+17.2%)
Jun 2001
-
$5.32M(+44.4%)
Mar 2001
-
$3.68M(-46.9%)
Dec 2000
$6.94M(+34.2%)
$6.94M(+89.0%)
Sep 2000
-
$3.67M(+26.9%)
Jun 2000
-
$2.89M(-39.2%)
Mar 2000
-
$4.76M(-8.0%)
Dec 1999
$5.17M(+145.1%)
$5.17M(-9.3%)
Sep 1999
-
$5.70M(-83.2%)
Jun 1999
-
$34.00M(+1900.0%)
Mar 1999
-
$1.70M
Dec 1998
$2.11M
-

FAQ

  • What is BioMarin Pharmaceutical annual total liabilities?
  • What is the all time high annual total liabilities for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical annual total liabilities year-on-year change?
  • What is BioMarin Pharmaceutical quarterly total liabilities?
  • What is the all time high quarterly total liabilities for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical quarterly total liabilities year-on-year change?

What is BioMarin Pharmaceutical annual total liabilities?

The current annual total liabilities of BMRN is $1.33B

What is the all time high annual total liabilities for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high annual total liabilities is $1.89B

What is BioMarin Pharmaceutical annual total liabilities year-on-year change?

Over the past year, BMRN annual total liabilities has changed by -$559.10M (-29.58%)

What is BioMarin Pharmaceutical quarterly total liabilities?

The current quarterly total liabilities of BMRN is $1.35B

What is the all time high quarterly total liabilities for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high quarterly total liabilities is $2.10B

What is BioMarin Pharmaceutical quarterly total liabilities year-on-year change?

Over the past year, BMRN quarterly total liabilities has changed by -$445.31M (-24.76%)
On this page